시장보고서

상품코드

1728056

잔류 용제 시장 규모, 점유율, 동향 분석 보고서 : 유형별, 용도별, 지역별 부문 예측(2025-2030년)

Residual Solvents Market Size, Share & Trends Analysis Report By Type (Class 1, Class 2, Class 3), By Application (Pharmaceutical, Food & Beverage, Industrial, Cosmetics), By Region, And Segment Forecasts, 2025 - 2030

발행일: 2025년 04월 | 리서치사:

Grand View Research | 페이지 정보: 영문 80 Pages | 배송안내 : 2-10일 (영업일 기준)

샘플 요청 목록에 추가

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

잔류 용제 시장 성장과 동향 :

Grand View Research, Inc.의 최신 보고서에 따르면 세계의 잔류 용제 시장 규모는 2025년부터 2030년까지 연평균 복합 성장률(CAGR) 5.0%를 나타내, 2030년에는 20억 달러에 달할 것으로 예측됩니다.

제약 및 바이오테크놀러지 산업, 특히 의약품 제제, API 제조, 생물 제제의 확대에 의해 용제 시험 수요가 증가하고 있습니다. 또한, 화장품이나 식품 안전에 있어서의 소비자의 의식과 품질 기준의 고조가 시장 성장을 한층 더 촉진하고 있습니다.

클래스 2 부문은 예측 기간 동안 2024년 수익 점유율 38.9%로 잔류용제 업계를 지배했습니다. 메탄올, 톨루엔, 디클로로메탄 등이 그 예에서 제조 공정에서 일반적으로 사용되지만 건강 위험을 최소화하기 위해 ICH 가이드 라인에 의한 엄격한 규제가 필요합니다.

예측 기간 동안 2024년의 수익 점유율은 58.3%로 의약품 부문이 시장을 독점했습니다. 의약품의 안전성과 컴플라이언스를 확보하기 위해 엄격한 용제제한을 실시했습니다.

예측기간 중 2024년 시장 점유율은 북미가 54.34%로 시장을 독점했습니다.(GC-MS)와 같은 분석기술의 진보도 시장 성장의 원동력이 되고 있습니다.

잔류 용제 시장 보고서 하이라이트

클래스 2 부문은 이러한 용제의 독성이 중간 정도이므로 의약품, 식품 및 화장품에 엄격한 규제가 필요하며 2024년에는 38.9%의 최대 수익 점유율을 차지했습니다. 톨루엔, 메탄올, 디클로로메탄 등의 용제는 널리 사용되고 있지만, 제품의 안전성을 확보하기 위해 ICH의 허용일일 노출량(PDE) 제한을 준수해야 합니다.
2024년 매출액 점유율은 54.34%로 북미가 잔류 용제 업계의 지배적인 지역이었습니다.
2023년 3월, 미국 약전(USP)은 불순물에 대한 업데이트된 ICH 가이드라인 Q3C(R8)에 맞춰 <467> "잔류 용매" 챕터를 개정했습니다. 두 유형 2 용제, 시클로 펜틸 메틸 에테르와 3 차 부틸 알코올, 1 유형 3 용제, 2- 메틸 테트라 히드로 푸란이 도입되었으며 관련 섹션과 부록의 업데이트가 필요했습니다.

세계의 잔류 용제 시장 전망
밸류체인 분석
- 원재료 전망
- 음식/제품 전망
- 판매 채널 분석
가격 동향 분석
- 가격에 영향을 미치는 요인
규제 프레임워크
- 표준 및 컴플라이언스
시장 역학
- 시장 성장 촉진요인 분석
- 시장 성장 억제요인 분석
- 시장 과제 분석
- 시장 기회 분석
Porter's Five Forces 분석
- 공급기업의 협상력
- 구매자의 협상력
- 대체 위협
- 신규 참가업체의 위협
- 경쟁 기업간 경쟁 관계
PESTLE 분석
- 정치
- 경제
- 사회
- 제품
- 환경
- 법률

제4장 잔류 용제 시장 : 유형의 추정·동향 분석

잔류 용제 시장 : 유형 변동 분석(2023년, 2030년)
클래스 1
클래스 2
클래스 3

제5장 잔류 용제 시장 : 용도의 추정·동향 분석

잔류 용제 시장 : 용도 변동 분석(2023년, 2030년)
의약품
식음료
화장품
산업

제6장 잔류 용제 시장 : 지역의 추정·동향 분석

지역 분석(2023년, 2030년)
북미
- 유형별(2018-2030년)
- 용도별(2018-2030년)
- 미국
- 캐나다
- 멕시코
유럽
- 유형별(2018-2030년)
- 용도별(2018-2030년)
- 독일
- 영국
- 프랑스
- 이탈리아
- 스페인
아시아태평양
- 유형별(2018-2030년)
- 용도별(2018-2030년)
- 중국
- 인도
- 일본
- 한국
라틴아메리카
- 유형별(2018-2030년)
- 용도별(2018-2030년)
- 브라질
- 아르헨티나
중동 및 아프리카
- 유형별(2018-2030년)
- 용도별(2018-2030년)
- 사우디아라비아
- 남아프리카

제7장 경쟁 구도

주요 시장 진출기업의 최근 동향
기업 분류
기업 히트맵 분석
기업의 시장 포지셔닝 분석(2024년)
전략 매핑
기업 프로파일/상장 기업
- Agilent Technology
- Thermo Fisher Scientific
- Techcomp
- LECO
- Fuli Instruments
- Shimadzu
- PerkinElmer
- Beifenruili
- Bruker

KTH 25.05.30

Residual Solvents Market Growth & Trends:

The global residual solvents market size is anticipated to reach USD 2.00 billion by 2030, registering a CAGR of 5.0% from 2025 to 2030, according to a new report by Grand View Research, Inc. The expansion of the pharmaceutical and biotechnology industries, particularly in drug formulation, API manufacturing, and biologics, increases the demand for solvent testing. Additionally, growing consumer awareness and quality standards in cosmetics and food safety further propel market growth. Technological advancements in gas chromatography (GC) and mass spectrometry (GC-MS) enhance detection accuracy, driving adoption.

The class 2 segment dominated the residual solvents industry with a revenue share of 38.9% in 2024, during the forecast period. Class 2 residual solvents are solvents with moderate toxicity that must be limited in pharmaceutical, food, and cosmetic products to ensure safety. Examples include methanol, toluene, and dichloromethane, which are commonly used in manufacturing but require strict regulation under ICH guidelines to minimize health risks.

The pharmaceuticals segment dominated the market with a revenue share of 58.3% in 2024, during the forecast period. The pharmaceutical segment dominated due to the extensive use of solvents in drug synthesis, formulation, and purification. Regulatory bodies like the FDA, ICH, and EMA enforce strict solvent limits to ensure drug safety and compliance. Advanced analytical techniques such as gas chromatography (GC) and mass spectrometry (GC-MS) are widely used for solvent detection in pharmaceutical manufacturing.

North America dominated the market with a market share of 54.34% in 2024, during the forecast period. The region's well-established pharmaceutical and biotechnology industries, along with advancements in analytical technologies like gas chromatography (GC) and mass spectrometry (GC-MS), drive market growth. Additionally, increasing consumer awareness, demand for high-purity products, and the presence of leading analytical instrument manufacturers further boost the market.

Residual Solvents Market Report Highlights:

The class 2 segment is held the largest revenue share of 38.9% in 2024.The Class 2 segment held the largest share due to the moderate toxicity of these solvents, requiring strict regulation in pharmaceuticals, food, and cosmetics. Solvents like toluene, methanol, and dichloromethane are widely used but must comply with ICH-permissible daily exposure (PDE) limits to ensure product safety.
North America was the dominant region for the residual solvents industry with a revenue share of 54.34% in 2024. North America led the market due to strict regulatory standards from the FDA, USP, and ICH, ensuring safety in pharmaceuticals, food, and cosmetics. The region's strong pharmaceutical sector and advancements in analytical technologies further drive market growth.
In March 2023, The United States Pharmacopeia (USP) has revised Chapter <467> "Residual Solvents" to align with the updated ICH guideline Q3C (R8) on impurities. This revision introduces two Class 2 solvents, cyclopentyl methyl ether and tertiary butyl alcohol, and one Class 3 solvent, 2-methyltetrahydrofuran, necessitating updates to related sections and appendices.

Chapter 1. Methodology and Scope

1.1. Market Segmentation & Scope
1.2. Market Definition
1.3. Information Procurement
- 1.3.1. Information Analysis
- 1.3.2. Market Formulation & Data Visualization
- 1.3.3. Data Validation & Publishing
1.4. Research Scope and Assumptions
- 1.4.1. List of Data Sources

Chapter 2. Executive Summary

2.1. Market Snapshot
2.2. Segmental Outlook
2.3. Competitive Outlook

Chapter 3. Market Variables, Trends, and Scope

3.1. Global Residual Solvents Market Outlook
3.2. Value Chain Analysis
- 3.2.1. Raw Material Outlook
- 3.2.2. Food & Beverage/Product Outlook
- 3.2.3. Sales Channel Analysis
3.3. Price Trend Analysis
- 3.3.1. Factors Influencing Prices
3.4. Regulatory Framework
- 3.4.1. Standards & Compliances
3.5. Market Dynamics
- 3.5.1. Market Driver Analysis
- 3.5.2. Market Restraint Analysis
- 3.5.3. Market Challenges Analysis
- 3.5.4. Market Opportunity Analysis
3.6. Porter's Five Forces Analysis
- 3.6.1. Bargaining Power of Suppliers
- 3.6.2. Bargaining Power of Buyers
- 3.6.3. Threat of Substitution
- 3.6.4. Threat of New Entrants
- 3.6.5. Competitive Rivalry
3.7. PESTLE Analysis
- 3.7.1. Political
- 3.7.2. Economic
- 3.7.3. Social Landscape
- 3.7.4. Product
- 3.7.5. Environmental
- 3.7.6. Legal

Chapter 4. Residual Solvents Market: Type Estimates & Trend Analysis

4.1. Residual Solvents Market: Type Movement Analysis, 2023 & 2030
4.2. Class 1
- 4.2.1. Market estimates and forecasts, 2018 - 2030 (USD Billion)
4.3. Class 2
- 4.3.1. Market estimates and forecasts, 2018 - 2030 (USD Billion)
4.4. Class 3
- 4.4.1. Market estimates and forecasts, 2018 - 2030 (USD Billion)

Chapter 5. Residual Solvents Market: Application Estimates & Trend Analysis

5.1. Residual Solvents Market: Application Movement Analysis, 2023 & 2030
5.2. Pharmaceuticals
- 5.2.1. Market estimates and forecasts, 2018 - 2030 (USD Billion)
5.3. Food & Beverage
- 5.3.1. Market estimates and forecasts, 2018 - 2030 (USD Billion)
5.4. Cosmetics
- 5.4.1. Market estimates and forecasts, 2018 - 2030 (USD Billion)
5.5. Industrial
- 5.5.1. Market estimates and forecasts, 2018 - 2030 (USD Billion)

Chapter 6. Residual Solvents Market: Regional Estimates & Trend Analysis

6.1. Regional Analysis, 2023 & 2030
6.2. North America
- 6.2.1. Market estimates and forecasts, 2018 - 2030 (USD Billion)
- 6.2.2. Market estimates and forecasts, by type, 2018 - 2030 (USD Billion)
- 6.2.3. Market estimates and forecasts, by application, 2018 - 2030 (USD Billion)
- 6.2.4. U.S.
  - 6.2.4.1. Market estimates and forecasts, 2018 - 2030 (USD Billion)
  - 6.2.4.2. Market estimates and forecasts, by type, 2018 - 2030 (USD Billion)
  - 6.2.4.3. Market estimates and forecasts, by application, 2018 - 2030 (USD Billion)
- 6.2.5. Canada
  - 6.2.5.1. Market estimates and forecasts, 2018 - 2030 (USD Billion)
  - 6.2.5.2. Market estimates and forecasts, by type, 2018 - 2030 (USD Billion)
  - 6.2.5.3. Market estimates and forecasts, by application, 2018 - 2030 (USD Billion)
- 6.2.6. Mexico
  - 6.2.6.1. Market estimates and forecasts, 2018 - 2030 (USD Billion)
  - 6.2.6.2. Market estimates and forecasts, by type, 2018 - 2030 (USD Billion)
  - 6.2.6.3. Market estimates and forecasts, by application, 2018 - 2030 (USD Billion)
6.3. Europe
- 6.3.1. Market estimates and forecasts, 2018 - 2030 (USD Billion)
- 6.3.2. Market estimates and forecasts, by type, 2018 - 2030 (USD Billion)
- 6.3.3. Market estimates and forecasts, by application, 2018 - 2030 (USD Billion)
- 6.3.4. Germany
  - 6.3.4.1. Market estimates and forecasts, 2018 - 2030 (USD Billion)
  - 6.3.4.2. Market estimates and forecasts, by type, 2018 - 2030 (USD Billion)
  - 6.3.4.3. Market estimates and forecasts, by application, 2018 - 2030 (USD Billion)
- 6.3.5. UK
  - 6.3.5.1. Market estimates and forecasts, 2018 - 2030 (USD Billion)
  - 6.3.5.2. Market estimates and forecasts, by type, 2018 - 2030 (USD Billion)
  - 6.3.5.3. Market estimates and forecasts, by application, 2018 - 2030 (USD Billion)
- 6.3.6. France
  - 6.3.6.1. Market estimates and forecasts, 2018 - 2030 (USD Billion)
  - 6.3.6.2. Market estimates and forecasts, by type, 2018 - 2030 (USD Billion)
  - 6.3.6.3. Market estimates and forecasts, by application, 2018 - 2030 (USD Billion)
- 6.3.7. Italy
  - 6.3.7.1. Market estimates and forecasts, 2018 - 2030 (USD Billion)
  - 6.3.7.2. Market estimates and forecasts, by type, 2018 - 2030 (USD Billion)
  - 6.3.7.3. Market estimates and forecasts, by application, 2018 - 2030 (USD Billion)
- 6.3.8. Spain
  - 6.3.8.1. Market estimates and forecasts, 2018 - 2030 (USD Billion)
  - 6.3.8.2. Market estimates and forecasts, by type, 2018 - 2030 (USD Billion)
  - 6.3.8.3. Market estimates and forecasts, by application, 2018 - 2030 (USD Billion)
6.4. Asia Pacific
- 6.4.1. Market estimates and forecasts, 2018 - 2030 (USD Billion)
- 6.4.2. Market estimates and forecasts, by type, 2018 - 2030 (USD Billion)
- 6.4.3. Market estimates and forecasts, by application, 2018 - 2030 (USD Billion)
- 6.4.4. China
  - 6.4.4.1. Market estimates and forecasts, 2018 - 2030 (USD Billion)
  - 6.4.4.2. Market estimates and forecasts, by type, 2018 - 2030 (USD Billion)
  - 6.4.4.3. Market estimates and forecasts, by application, 2018 - 2030 (USD Billion)
- 6.4.5. India
  - 6.4.5.1. Market estimates and forecasts, 2018 - 2030 (USD Billion)
  - 6.4.5.2. Market estimates and forecasts, by type, 2018 - 2030 (USD Billion)
  - 6.4.5.3. Market estimates and forecasts, by application, 2018 - 2030 (USD Billion)
- 6.4.6. Japan
  - 6.4.6.1. Market estimates and forecasts, 2018 - 2030 (USD Billion)
  - 6.4.6.2. Market estimates and forecasts, by type, 2018 - 2030 (USD Billion)
  - 6.4.6.3. Market estimates and forecasts, by application, 2018 - 2030 (USD Billion)
- 6.4.7. South Korea
  - 6.4.7.1. Market estimates and forecasts, 2018 - 2030 (USD Billion)
  - 6.4.7.2. Market estimates and forecasts, by type, 2018 - 2030 (USD Billion)
  - 6.4.7.3. Market estimates and forecasts, by application, 2018 - 2030 (USD Billion)
6.5. Latin America
- 6.5.1. Market estimates and forecasts, 2018 - 2030 (USD Billion)
- 6.5.2. Market estimates and forecasts, by type, 2018 - 2030 (USD Billion)
- 6.5.3. Market estimates and forecasts, by application, 2018 - 2030 (USD Billion)
- 6.5.4. Brazil
  - 6.5.4.1. Market estimates and forecasts, 2018 - 2030 (USD Billion)
  - 6.5.4.2. Market estimates and forecasts, by type, 2018 - 2030 (USD Billion)
  - 6.5.4.3. Market estimates and forecasts, by application, 2018 - 2030 (USD Billion)
- 6.5.5. Argentina
  - 6.5.5.1. Market estimates and forecasts, 2018 - 2030 (USD Billion)
  - 6.5.5.2. Market estimates and forecasts, by type, 2018 - 2030 (USD Billion)
  - 6.5.5.3. Market estimates and forecasts, by application, 2018 - 2030 (USD Billion)
6.6. Middle East & Africa
- 6.6.1. Market estimates and forecasts, 2018 - 2030 (USD Billion)
- 6.6.2. Market estimates and forecasts, by type, 2018 - 2030 (USD Billion)
- 6.6.3. Market estimates and forecasts, by application, 2018 - 2030 (USD Billion)
- 6.6.4. Saudi Arabia
  - 6.6.4.1. Market estimates and forecasts, 2018 - 2030 (USD Billion)
  - 6.6.4.2. Market estimates and forecasts, by type, 2018 - 2030 (USD Billion)
  - 6.6.4.3. Market estimates and forecasts, by application, 2018 - 2030 (USD Billion)
- 6.6.5. South Africa
  - 6.6.5.1. Market estimates and forecasts, 2018 - 2030 (USD Billion)
  - 6.6.5.2. Market estimates and forecasts, by type, 2018 - 2030 (USD Billion)
  - 6.6.5.3. Market estimates and forecasts, by application, 2018 - 2030 (USD Billion)

Chapter 7. Competitive Landscape

7.1. Recent Developments by Key Market Participants
7.2. Company Categorization
7.3. Company Heat Map Analysis
7.4. Company Market Positioning Analysis, 2024
7.5. Strategy Mapping
7.6. Company Profiles/Listing
- 7.6.1. Agilent Technology
  - 7.6.1.1. Company Overview
  - 7.6.1.2. Financial Performance
  - 7.6.1.3. Product Benchmarking
- 7.6.2. Thermo Fisher Scientific
  - 7.6.2.1. Company Overview
  - 7.6.2.2. Financial Performance
  - 7.6.2.3. Product Benchmarking
- 7.6.3. Techcomp
  - 7.6.3.1. Company Overview
  - 7.6.3.2. Financial Performance
  - 7.6.3.3. Product Benchmarking
- 7.6.4. LECO
  - 7.6.4.1. Company Overview
  - 7.6.4.2. Financial Performance
  - 7.6.4.3. Product Benchmarking
- 7.6.5. Fuli Instruments
  - 7.6.5.1. Company Overview
  - 7.6.5.2. Financial Performance
  - 7.6.5.3. Product Benchmarking
- 7.6.6. Shimadzu
  - 7.6.6.1. Company Overview
  - 7.6.6.2. Financial Performance
  - 7.6.6.3. Product Benchmarking
- 7.6.7. PerkinElmer
  - 7.6.7.1. Company Overview
  - 7.6.7.2. Financial Performance
  - 7.6.7.3. Product Benchmarking
- 7.6.8. Beifenruili
  - 7.6.8.1. Company Overview
  - 7.6.8.2. Financial Performance
  - 7.6.8.3. Product Benchmarking
- 7.6.9. Bruker
  - 7.6.9.1. Company Overview
  - 7.6.9.2. Financial Performance
  - 7.6.9.3. Product Benchmarking